CAMBRIDGE, Mass.--(BUSINESS WIRE)--Visterra, Inc., developer of novel therapeutics to treat major diseases, announced today that it has appointed Donna M. Ambrosino, M.D., as chief medical officer. Dr. Ambrosino will oversee all drug development activities for the company, including the company’s lead drug candidate against influenza, VIS410, and she will serve as a member of the company’s executive management team.
